These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9143794

  • 1. Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cells.
    Ginsberg HN.
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):A29-32. PubMed ID: 9143794
    [Abstract] [Full Text] [Related]

  • 2. Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome.
    Pariyarath R, Wang H, Aitchison JD, Ginsberg HN, Welch WJ, Johnson AE, Fisher EA.
    J Biol Chem; 2001 Jan 05; 276(1):541-50. PubMed ID: 11022045
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes.
    Taghibiglou C, Rudy D, Van Iderstine SC, Aiton A, Cavallo D, Cheung R, Adeli K.
    J Lipid Res; 2000 Apr 05; 41(4):499-513. PubMed ID: 10744770
    [Abstract] [Full Text] [Related]

  • 5. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
    Zhou M, Fisher EA, Ginsberg HN.
    J Biol Chem; 1998 Sep 18; 273(38):24649-53. PubMed ID: 9733761
    [Abstract] [Full Text] [Related]

  • 6. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70.
    Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, Wang H, Goldberg AL, Ginsberg HN.
    J Biol Chem; 1997 Aug 15; 272(33):20427-34. PubMed ID: 9252351
    [Abstract] [Full Text] [Related]

  • 7. Efficient glycosylation site utilization by intracellular apolipoprotein B. Implications for proteasomal degradation.
    Huang XF, Shelness GS.
    J Lipid Res; 1999 Dec 15; 40(12):2212-22. PubMed ID: 10588947
    [Abstract] [Full Text] [Related]

  • 8. Hepatic synthesis of lipoproteins and apolipoproteins.
    Dixon JL, Ginsberg HN.
    Semin Liver Dis; 1992 Nov 15; 12(4):364-72. PubMed ID: 1465621
    [Abstract] [Full Text] [Related]

  • 9. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
    Liao W, Yeung SC, Chan L.
    J Biol Chem; 1998 Oct 16; 273(42):27225-30. PubMed ID: 9765244
    [Abstract] [Full Text] [Related]

  • 10. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
    Macri J, Adeli K.
    Arterioscler Thromb Vasc Biol; 1997 Nov 16; 17(11):2982-94. PubMed ID: 9409285
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein B: from editosome to proteasome.
    Chan L, Chang BH, Liao W, Oka K, Lau PP.
    Recent Prog Horm Res; 2000 Nov 16; 55():93-125; discussion 126. PubMed ID: 11036935
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the synthesis of apolipoprotein B-containing lipoproteins.
    Greeve J.
    Handb Exp Pharmacol; 2005 Nov 16; (170):483-517. PubMed ID: 16596812
    [Abstract] [Full Text] [Related]

  • 13. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains.
    Liang J, Wu X, Jiang H, Zhou M, Yang H, Angkeow P, Huang LS, Sturley SL, Ginsberg H.
    J Biol Chem; 1998 Dec 25; 273(52):35216-21. PubMed ID: 9857060
    [Abstract] [Full Text] [Related]

  • 14. Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.
    Wu X, Shang A, Jiang H, Ginsberg HN.
    Arterioscler Thromb Vasc Biol; 1997 Nov 25; 17(11):3347-55. PubMed ID: 9409332
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells.
    Liao W, Chan L.
    J Biol Chem; 2000 Feb 11; 275(6):3950-6. PubMed ID: 10660549
    [Abstract] [Full Text] [Related]

  • 16. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways.
    Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks JD, Williams KJ.
    J Biol Chem; 2001 Jul 27; 276(30):27855-63. PubMed ID: 11285257
    [Abstract] [Full Text] [Related]

  • 17. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W, Chang BH, Mancini M, Chan L.
    J Cell Biochem; 2003 Aug 01; 89(5):1019-29. PubMed ID: 12874835
    [Abstract] [Full Text] [Related]

  • 18. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J, Kazemian P, Kulinski A, Rudy D, Aiton A, Thibert RJ, Adeli K.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1035-47. PubMed ID: 11027587
    [Abstract] [Full Text] [Related]

  • 19. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
    Davidson NO, Shelness GS.
    Annu Rev Nutr; 2000 Oct 05; 20():169-93. PubMed ID: 10940331
    [Abstract] [Full Text] [Related]

  • 20. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
    Wang Q, Theriault A, Gapor A, Adeli K.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):640-3. PubMed ID: 9618265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.